March 2023

March 17, 2023

JUUL LABS PUBLISHES WHITE PAPER EXAMINING THE REAL-WORLD IMPACT OF ENDS PRODUCTS FOR ADULT SMOKERS

In a new white paper entitled “The Real-World Impact of ENDS for Adult Smokers: Tobacco Harm Reduction Through Real-World Data and Evidence,” Juul Labs has reviewed and compiled the latest science and evidence demonstrating the positive real-world impact of ENDS products for adult smokers.

March 2022

March 17, 2022

PEER-REVIEWED STUDY FINDS BANNING VAPOR PRODUCTS MAY LEAD TO INCREASED CIGARETTE SALES

This research shows that policies that significantly restrict vapor products are likely deterring current adult smokers from switching and driving former adult smokers back to combustible cigarettes, which remain the leading cause of preventable death in the U.S. and worldwide.

May 2021

May 21, 2021

STUDY FINDS TECHNOLOGICAL SOLUTIONS DRAMATICALLY IMPROVE RETAILER COMPLIANCE, MAY HELP RESTRICT UNDERAGE ACCESS TO VAPOR PRODUCTS

Juul Labs recently published a study through Qeios analyzing the effectiveness of Enhanced Access Controls using publicly-available data from FDA’s compliance-check inspections of tobacco product retailers.

May 18, 2021

PEER-REVIEWED STUDY COMPARES RATES OF SWITCHING AWAY FROM CIGARETTES AMONG ADULT SMOKERS WHO PURCHASED THE JUUL SYSTEM IN UNITED STATES, CANADA, AND EUROPE

A new peer-reviewed study from Juul Labs found that found that while rates of complete switching from cigarettes to JUUL products among adult smokers who purchase JUUL products in the United Kingdom are encouraging, they are lower than switch rates among similar smokers in the United States and Canada, where higher nicotine concentration products are available.

April 2021

April 27, 2021

JUUL LABS CHIEF REGULATORY OFFICER, JOE MURILLO, DETAILS MONOGRAPH PUBLICATION IN FOOD & DRUG LAW INSTITUTE NEWSLETTER

Juul Labs’ Chief Regulatory Officer, Joe Murillo, published a piece entitled “Juul Labs: Advancing the Scientific Dialogue About Tobacco Harm Reduction” in the Food & Drug Law Institute (FDLI) newsletter.

April 26, 2021

JUUL LABS ANNOUNCES PUBLICATION OF 11 PEER-REVIEWED STUDIES IN MONOGRAPH EDITION OF THE AMERICAN JOURNAL OF HEALTH BEHAVIOR

This month we celebrate a significant milestone in our efforts to expand the body of evidence surrounding vapor products with the publication of 11 peer-reviewed studies in a monograph edition of the American Journal of Health Behavior (AJHB).

February 2021

February 24, 2021

JUUL LABS SHARES FINDINGS FROM 11 SCIENTIFIC STUDIES

Juul Labs today announced findings from its science and research program at the 2021 Annual Meeting of the Society for Research on Nicotine & Tobacco (SRNT), which was held virtually.

January 2021

January 25, 2021

PEER-REVIEWED STUDY COMPARES NICOTINE DELIVERY OF COMBUSTIBLE CIGARETTES TO JUUL PRODUCTS AVAILABLE IN UNITED STATES, CANADA, AND EUROPE

A separate study of JUUL purchasers found higher rates of complete transitioning away from cigarettes among adult smokers in the US and Canada than in the United Kingdom, where the JUUL System is only available in lower concentrations of nicotine.

November 2020

November 11, 2020

JUUL SYSTEM DELIVERS NICOTINE AT SUFFICIENT LEVELS TO COMPETE WITH COMBUSTIBLE CIGARETTES, NEW STUDY SUGGESTS

A clinical study recently published in the journal Drug and Alcohol Dependence compared the nicotine delivery profile of the JUUL System with other nicotine-containing products, including cigarettes, in order to assess their pharmacokinetic or “PK” profiles

September 2020

September 21, 2020

NEW RESEARCH SUGGESTS STATE BANS ON ENDS PRODUCTS IN THE UNITED STATES MAY HAVE UNINTENDED CONSEQUENCES, INCLUDING INCREASES IN CIGARETTE SALES

Unacceptable levels of underage use have eroded public trust in our industry, leading to the introduction of well-intentioned state-level product bans that may have…